TAYD · Insider Trading
Taylor Devices Inc
Every open-market purchase and sale reported by TAYD officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-05 | John Burgess | Director | M | +5,000 | +$69.00K |
| 2026-04-20 | Fritz Eric Armenat | Director | A | −7,000 deriv. | — |
| 2026-04-20 | Robert Michael Carey | Director | A | −7,000 deriv. | — |
| 2026-04-20 | John Burgess | Director | A | −7,000 deriv. | — |
| 2026-04-20 | Paul Murray Heary | Chief Financial Officer | A | −7,000 deriv. | — |
| 2026-04-20 | Timothy John Sopko | Chief Executive Officer | A | −7,000 deriv. | — |
| 2026-04-15 | John Burgess | Director | MIXED | +3,426 | −$16 |
| 2026-01-26 | Fritz Eric Armenat | Director | Sell | −4,328 | −$311.39K |
| 2026-01-23 | Fritz Eric Armenat | Director | MIXED | +4,328 | +$4 |
| 2026-01-16 | Fritz Eric Armenat | Director | Sell | −4,120 | −$301.86K |
| 2026-01-13 | Fritz Eric Armenat | Director | MIXED | +4,120 | −$19 |
| 2025-04-24 | Timothy John Sopko | Chief Executive Officer | Buy | +1,000 | +$30.03K |
| 2025-04-22 | Robert Michael Carey | Director | A | −7,000 deriv. | — |
| 2025-04-22 | Timothy John Sopko | Chief Executive Officer | A | −7,000 deriv. | — |
| 2025-04-22 | Fritz Eric Armenat | Director | A | −7,000 deriv. | — |
| 2025-04-22 | Paul Murray Heary | Chief Financial Officer | A | −7,000 deriv. | — |
| 2025-04-22 | Alan Raymond Klembczyk | President | A | −7,000 deriv. | — |
| 2025-04-22 | John Burgess | Director | A | −7,000 deriv. | — |
| 2025-04-16 | John Burgess | Director | M | +5,000 | +$61.00K |
| 2025-01-14 | Timothy John Sopko | Chief Executive Officer | Buy | +1,000 | +$33.25K |
| 2024-10-29 | Robert Michael Carey | Director | MIXED | +7,721 | −$0 |
| 2024-09-19 | Alan Raymond Klembczyk | President | M | +8,000 | +$86.03K |
| 2024-04-19 | Alan Raymond Klembczyk | President | A | +7,000 deriv. | — |
| 2024-04-19 | Fritz Eric Armenat | Director | A | +7,000 deriv. | — |
| 2024-04-19 | Robert Michael Carey | Director | A | +7,000 deriv. | — |
| 2024-04-19 | John Burgess | Director | A | −7,000 deriv. | — |
| 2024-04-19 | Paul Murray Heary | Chief Financial Officer | A | +7,000 deriv. | — |
| 2024-04-19 | Timothy John Sopko | Chief Executive Officer | A | +7,000 deriv. | — |
| 2024-04-09 | John Burgess | Director | M | +5,000 | +$44.93K |
| 2024-01-17 | Ira Sochet | 10%+ Owner | Sell | −459,015 | −$9.14M |
| 2023-04-19 | Paul Murray Heary | Chief Financial Officer | A | +7,000 deriv. | — |
| 2023-04-19 | Robert Michael Carey | Director | A | +7,000 deriv. | — |
| 2023-04-19 | Fritz Eric Armenat | Director | A | +7,000 deriv. | — |
| 2023-04-19 | Timothy John Sopko | Chief Executive Officer | A | +7,000 deriv. | — |
| 2023-04-19 | John Burgess | Director | A | +7,000 deriv. | — |
| 2023-04-19 | Alan Raymond Klembczyk | President | A | +7,000 deriv. | — |
| 2023-03-17 | John Burgess | Director | M | +5,000 | +$38.70K |
| 2023-01-20 | Timothy John Sopko | Chief Executive Officer | Buy | +1,000 | +$14.10K |
| 2022-10-21 | Timothy John Sopko | CHIEF EXECUTIVE OFFICER | Buy | +1,000 | +$11.10K |
| 2022-10-05 | Robert Michael Carey | Director | Buy | +2,500 | +$26.74K |
| 2022-08-08 | Mark V McDonough | CHIEF FINANCIAL OFFICER | M | +4,000 | +$32.22K |
| 2022-04-22 | Robert Michael Carey | Director | A | +5,000 deriv. | — |
| 2022-04-22 | Timothy John Sopko | CHIEF EXECUTIVE OFFICER | A | +5,000 deriv. | — |
| 2022-04-22 | Fritz Eric Armenat | Director | A | +5,000 deriv. | — |
| 2022-04-22 | Alan Raymond Klembczyk | PRESIDENT | A | +5,000 deriv. | — |
| 2022-04-22 | Mark V McDonough | CHIEF FINANCIAL OFFICER | A | +5,000 deriv. | — |
| 2022-04-22 | John Burgess | Director | A | +5,000 deriv. | — |
| 2022-04-05 | Timothy John Sopko | CHIEF EXECUTIVE OFFICER | Buy | +1,000 | +$9.95K |
| 2022-01-24 | Timothy John Sopko | CHIEF EXECUTIVE OFFICER | Buy | +1,000 | +$10.38K |
| 2021-10-04 | Timothy John Sopko | CHIEF EXECUTIVE OFFICER | Buy | +1,000 | +$11.25K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| John Burgess | Director | 48,426 | $2.88M |
| Robert Michael Carey | Director | 10,000 | $593.80K |
| Timothy John Sopko | Chief Executive Officer | 9,710 | $576.58K |
| Alan Raymond Klembczyk | President | 5,123 | $304.20K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the TAYD quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.